Pine Labs Q4 FY26 Results Analysis: EBITDA Margin Beats Guidance, Operating Cash Flow Surges 8x

CompoundingAI Research Updated May 25, 2026 2 min read

Pine Labs Ltd reported Q4 FY26 numbers. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateMay 25, 2026
QuarterQ4 FY 2025-2026
Revenue (Q4)Rs. 2,710.59 Cr (+19.20% YoY)
PAT (Q4)Rs. 112.51 Cr
EBITDA margin20.60% (+500 bps YoY)
EPS (Q4)Rs. 1.05
Market capRs. 16,404.20 Cr
CMPRs. 142.84

Quarter Snapshot

Pine Labs delivered its first full year of profitability, with PAT swinging Rs.258 Cr from a loss to Rs.112.51 Cr. The adjusted EBITDA margin of 20.6% beat management's guidance of 19-20%, while operating cash flow surged 8x to Rs.395 Cr and debt was cut by 66%, strengthening the balance sheet significantly.

Key Investment Insights

Key Positives

  • First full year of profitability with PAT of Rs.112.51 Cr vs loss of Rs.145.49 Cr in FY25.
  • Adjusted EBITDA margin expanded 500 bps YoY to 20.6%, exceeding management guidance of 19-20%.
  • Operating cash flow grew 8x YoY to Rs.395.39 Cr from Rs.49.72 Cr.
  • Total debt reduced 65.9% to Rs.282.87 Cr from Rs.829.49 Cr, improving net worth by 68.1%.
  • International revenue grew at 44% 3-year CAGR, now 15% of total revenue.
  • Gross Transaction Value grew 50% YoY to $194 Bn, indicating monetization headroom.

Risk Factors

  • Subsidiaries create a 25% drag on consolidated PAT, with a loss of Rs.37.37 Cr in FY26.
  • GST demand of Rs.37.33 Cr contested via appeal, representing a contingent liability.
  • Revenue declined 5.9% QoQ in Q4 FY26, though partly seasonal.
  • Issuing & Acquiring segment contribution margin compressed 550 bps YoY to 55.4% in Q4.
Share on X · LinkedIn

Disclaimer: This is an AI-generated analysis based on public filings. It is not investment advice, not a recommendation to buy/sell/hold any security, and is not prepared by a SEBI-registered Research Analyst or Investment Adviser.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now